SCHEMBL21465510

SCHEMBL21465510

COC(=O)c1[nH]c2ccc(Cl)cc2c1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.60
ALDH1A1 P00352 6/20 0.60
HPGD P15428 5/20 0.60
TUBB4A P04350 5/20 0.58
TUBB P07437 5/20 0.58
TUBA3C P0DPH7 5/20 0.58
TUBA1B P68363 5/20 0.58
TUBA4A P68366 5/20 0.58
TUBB4B P68371 5/20 0.58
TUBB3 Q13509 5/20 0.58
TUBB2A Q13885 5/20 0.58
TUBB8 Q3ZCM7 5/20 0.58
TUBA3E Q6PEY2 5/20 0.58
TUBA1A Q71U36 5/20 0.58
TUBA1C Q9BQE3 5/20 0.58
TUBB6 Q9BUF5 5/20 0.58
TUBB2B Q9BVA1 5/20 0.58
TUBB1 Q9H4B7 5/20 0.58
NPSR1 Q6W5P4 3/20 0.57
GAA P10253 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6308065 0.84 KDM4E (0.58) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL25751659 0.84 KDM4E (0.58) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL21465557 0.84 TUBB4A (0.65) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL21465529 0.82 KMT2A (0.56) KDM4EALDH1A1HPGDNPSR1GAA
SCHEMBL21474560 0.82 ALDH1A1 (0.50) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL21465541 0.82 MAPT (0.57) KDM4EALDH1A1HPGDNPSR1GAA
SCHEMBL6313673 0.81 GSK3B (0.56) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL3253095 0.81 KDM4E (0.56) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL5402454 0.81 ALOX15 (0.60) KDM4EALDH1A1HPGDTUBB4ATUBB
SCHEMBL29953042 0.81 ALOX15 (0.60) KDM4EALDH1A1HPGDTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690824-B2 Antibacterial compounds THE GENERAL HOSPITAL CORPORATION (US) 2023-07-04 US disclosed
US-11690824-B2 Antibacterial compounds THE GENERAL HOSPITAL CORPORATION (US) 2023-07-04 US disclosed
US-11690824-B2 Antibacterial compounds THE GENERAL HOSPITAL CORPORATION (US) 2023-07-04 US disclosed
US-20210251958-A1 Antibacterial Compounds RHODE ISLAND HOSPITAL, A LIFESPAN-PARTNER 2021-08-19 US disclosed
US-20210251958-A1 Antibacterial Compounds RHODE ISLAND HOSPITAL, A LIFESPAN-PARTNER 2021-08-19 US disclosed
WO-2019199979-A1 ANTIBACTERIAL COMPOUNDS THE GENERAL HOSPITAL CORPORATION (US) 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690824-B2 Antibacterial compounds MRPL21, SPOUT1, BAX KDM4E 4594/4885ALDH1A1 2131/4885HPGD 502/4885
US-20210251958-A1 Antibacterial Compounds MRPL21, SPOUT1, BAX KDM4E 4594/4885ALDH1A1 2131/4885HPGD 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.